“Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors ”. 2023. The Review of Diabetic Studies 5 (2). https://diabeticstudies.org/index.php/RDS/article/view/287.